Lyme Disease,


Journal

Journal of the American Chemical Society
ISSN: 1520-5126
Titre abrégé: J Am Chem Soc
Pays: United States
ID NLM: 7503056

Informations de publication

Date de publication:
16 02 2022
Historique:
pubmed: 8 2 2022
medline: 12 3 2022
entrez: 7 2 2022
Statut: ppublish

Résumé

The human immune system detects potentially pathogenic microbes with receptors that respond to microbial metabolites. While the overall immune signaling pathway is known in considerable detail, the initial molecular signals, the microbially produced immunogens, for important diseases like Lyme disease (LD) are often not well-defined. The immunogens for LD are produced by the spirochete

Identifiants

pubmed: 35129341
doi: 10.1021/jacs.1c12202
doi:

Substances chimiques

Antigens, Bacterial 0
Galactolipids 0
Tlr2 protein, mouse 0
Toll-Like Receptor 2 0
Tumor Necrosis Factor-alpha 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2474-2478

Subventions

Organisme : NCCIH NIH HHS
ID : R01 AT009708
Pays : United States

Auteurs

Dávid Szamosvári (D)

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School and Blavatnik Institute, Boston, Massachusetts 02115, United States.

Munhyung Bae (M)

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School and Blavatnik Institute, Boston, Massachusetts 02115, United States.

Sunghee Bang (S)

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School and Blavatnik Institute, Boston, Massachusetts 02115, United States.

Betsabeh Khoramian Tusi (BK)

Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, United States.
Department of Molecular Biology, Massachusetts General Hospital, Boston, Massachusetts 02114, United States.
Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital, Boston, Massachusetts 02114, United States.

Chelsi D Cassilly (CD)

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School and Blavatnik Institute, Boston, Massachusetts 02115, United States.

Sung-Moo Park (SM)

Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, United States.
Department of Molecular Biology, Massachusetts General Hospital, Boston, Massachusetts 02114, United States.
Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital, Boston, Massachusetts 02114, United States.

Daniel B Graham (DB)

Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, United States.
Department of Molecular Biology, Massachusetts General Hospital, Boston, Massachusetts 02114, United States.
Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital, Boston, Massachusetts 02114, United States.

Ramnik J Xavier (RJ)

Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, United States.
Department of Molecular Biology, Massachusetts General Hospital, Boston, Massachusetts 02114, United States.
Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital, Boston, Massachusetts 02114, United States.

Jon Clardy (J)

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School and Blavatnik Institute, Boston, Massachusetts 02115, United States.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
C-Reactive Protein Humans Biomarkers Inflammation
Humans Immune Checkpoint Inhibitors Lung Neoplasms Prognosis Inflammation

Classifications MeSH